Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri.
University of Missouri-Kansas City School of Medicine, Kansas City.
JAMA Netw Open. 2023 Jun 1;6(6):e2320520. doi: 10.1001/jamanetworkopen.2023.20520.
Among patients seeking care for musculoskeletal conditions, there is mixed evidence regarding whether traditional, structure-based care is associated with improvement in patients' mental health.
To determine whether improvements in physical function and pain interference are associated with meaningful improvements in anxiety and depression symptoms among patients seeking musculoskeletal care.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included adult patients treated by an orthopedic department of a tertiary care US academic medical center from June 22, 2015, to February 9, 2022. Eligible participants presented between 4 and 6 times during the study period for 1 or more musculoskeletal conditions and completed Patient-Reported Outcomes Measurement Information System (PROMIS) measures as standard care at each visit.
PROMIS Physical Function and Pain Interference scores.
Linear mixed effects models were used to determine whether improvements in PROMIS Anxiety and PROMIS Depression scores were associated with improved PROMIS Physical Function or Pain Interference scores after controlling for age, gender, race, and PROMIS Depression (for the anxiety model) or PROMIS Anxiety (for the depression model). Clinically meaningful improvement was defined as 3.0 points or more for PROMIS Anxiety and 3.2 points or more for PROMIS Depression.
Among 11 236 patients (mean [SD] age, 57 [16] years), 7218 (64.2%) were women; 120 (1.1%) were Asian, 1288 (11.5%) were Black, and 9706 (86.4%) were White. Improvements in physical function (β = -0.14; 95% CI, -0.15 to -0.13; P < .001) and pain interference (β = 0.26; 95% CI, 0.25 to 0.26; P < .001) were each associated with improved anxiety symptoms. To reach a clinically meaningful improvement in anxiety symptoms, an improvement of 21 PROMIS points or more (95% CI, 20-23 points) on Physical Function or 12 points or more (95% CI, 12-12 points) on Pain Interference would be required. Improvements in physical function (β = -0.05; 95% CI, -0.06 to -0.04; P < .001) and pain interference (β = 0.04; 95% CI, 0.04 to 0.05; P < .001) were not associated with meaningfully improved depression symptoms.
In this cohort study, substantial improvements in physical function and pain interference were required for association with any clinically meaningful improvement in anxiety symptoms, and were not associated with any meaningful improvement in depression symptoms. Patients seeking musculoskeletal care clinicians providing treatment cannot assume that addressing physical health will result in improved symptoms of depression or potentially even sufficiently improved symptoms of anxiety.
在寻求肌肉骨骼疾病治疗的患者中,传统的基于结构的治疗方法是否与患者心理健康的改善相关,证据不一。
确定身体功能和疼痛干扰的改善是否与寻求肌肉骨骼护理的患者的焦虑和抑郁症状的有意义改善相关。
设计、地点和参与者:这项队列研究纳入了 2015 年 6 月 22 日至 2022 年 2 月 9 日期间在美国一家三级保健学术医疗中心的骨科部门接受治疗的成年患者。合格的参与者在研究期间每 4-6 次就诊一次,患有 1 种或多种肌肉骨骼疾病,并在每次就诊时作为标准护理完成 PROMIS(患者报告的结果测量信息系统)评估。
PROMIS 身体功能和疼痛干扰评分。
使用线性混合效应模型来确定 PROMIS 焦虑和 PROMIS 抑郁评分的改善是否与 PROMIS 身体功能或疼痛干扰评分的改善相关,在控制年龄、性别、种族和 PROMIS 抑郁(用于焦虑模型)或 PROMIS 焦虑(用于抑郁模型)后。有临床意义的改善定义为 PROMIS 焦虑改善 3.0 点或以上,PROMIS 抑郁改善 3.2 点或以上。
在 11236 名患者(平均[标准差]年龄 57[16]岁)中,7218 名(64.2%)为女性;120 名(1.1%)为亚洲人,1288 名(11.5%)为黑人,9706 名(86.4%)为白人。身体功能(β=-0.14;95%置信区间,-0.15 至-0.13;P<0.001)和疼痛干扰(β=0.26;95%置信区间,0.25 至 0.26;P<0.001)的改善均与焦虑症状的改善相关。为了达到焦虑症状的临床显著改善,身体功能(95%置信区间,20-23 分)或疼痛干扰(95%置信区间,12-12 分)需要改善 21 个 PROMIS 点或更多。身体功能(β=-0.05;95%置信区间,-0.06 至-0.04;P<0.001)和疼痛干扰(β=0.04;95%置信区间,0.04 至 0.05;P<0.001)的改善与抑郁症状的任何有临床意义的改善均无关。
在这项队列研究中,身体功能和疼痛干扰的大幅改善需要与焦虑症状的任何有临床意义的改善相关,而与抑郁症状的任何改善均无关。寻求肌肉骨骼护理的患者,为他们提供治疗的临床医生不能假设解决身体健康问题会导致抑郁症状的改善,甚至可能无法显著改善焦虑症状。